Oesophageal squamous cell carcinoma – Diagnostics – Overview of Information and Clinical Research

Oesophageal squamous cell carcinoma often remains hidden until it has spread beyond the esophagus, making early detection challenging. Because the esophagus is flexible and stretches around growing tumors, most people don’t experience noticeable symptoms in the early stages. Understanding when to seek diagnostic testing and what to expect during the process can make a significant difference in catching this aggressive disease at a stage where treatment may be more effective.

Introduction: Who Should Undergo Diagnostics

Oesophageal squamous cell carcinoma begins in the flat cells that line the inside of your esophagus, the muscular tube that carries food from your throat to your stomach. Unlike some cancers that develop slowly, this type typically grows very rapidly. However, because your esophagus is remarkably flexible and naturally expands to accommodate food, it also stretches around tumors as they grow. This flexibility means that early tumors rarely cause symptoms that would prompt you to seek medical attention.^[1]

The first symptom most people notice is difficulty swallowing, which typically begins with solid foods and then progresses to include liquids as the tumor grows larger and blocks more of the esophagus opening. By the time swallowing becomes difficult, the cancer has often already reached an advanced stage. Other warning signs that should prompt you to see a doctor include pain in your throat or back, behind your breastbone or between your shoulder blades, unexplained weight loss, vomiting or coughing up blood, persistent heartburn, hoarseness, or a chronic cough.^[1]

You should seek medical evaluation promptly if you experience any combination of these symptoms, especially if you have risk factors for esophageal cancer. The main risk factors include tobacco use in any form—whether smoking cigarettes or using smokeless tobacco—and chronic or heavy alcohol consumption. Using both tobacco and alcohol together increases your risk even more significantly than either habit alone. Other risk factors include being overweight or having obesity, which can cause inflammation in the esophagus, and having a condition called idiopathic achalasia, which is a disorder affecting the movement of food through the esophagus.^[5]^[6]

This type of cancer typically affects people between the ages of 60 and 70, and it is more frequently seen in males. It most commonly occurs in the upper and middle sections of the esophagus, which distinguishes it from adenocarcinoma, the other main type of esophageal cancer that usually develops in the lower part near the stomach.^[5]^[6]

⚠️ Important

Unfortunately, only about 25% of people with esophageal cancer receive a diagnosis before the cancer has spread to other parts of the body. This is why it’s critical to seek medical attention as soon as you notice persistent difficulty swallowing or any other concerning symptoms, rather than waiting to see if they resolve on their own.

Classic Diagnostic Methods

When you visit your doctor with symptoms that might suggest esophageal squamous cell carcinoma, the diagnostic process typically begins with a physical examination and a review of your medical history. Your doctor will ask about your health habits, past illnesses, and current symptoms. They will also check for general signs of disease, including any unusual lumps or other changes in your body.^[6]

A chest X-ray is often one of the first imaging tests ordered. This simple test uses a type of energy beam that passes through your body to create pictures of the organs and bones inside your chest. While a chest X-ray cannot definitively diagnose esophageal cancer, it can sometimes reveal abnormalities that warrant further investigation.^[6]

Barium Swallow Study

Another early diagnostic tool is the barium swallow study, which uses X-rays to examine your digestive system. Before this test, you drink a thick white liquid containing barium, a substance that coats the inside of your esophagus and makes it easier to see on X-ray images. The barium coating allows doctors to identify changes in the esophagus, such as narrowing, lumps, or other abnormalities that could indicate cancer. If something concerning appears on the barium swallow study, your healthcare team will typically recommend more detailed testing with an endoscopy.^[8]

Upper Endoscopy (Esophagoscopy)

The most important test for diagnosing esophageal squamous cell carcinoma is upper endoscopy, also called esophagoscopy. This procedure allows your doctor to look directly inside your esophagus to check for abnormal areas. An endoscope—a thin, flexible tube equipped with a light and a tiny camera at its tip—is gently inserted through your mouth or nose, down your throat, and into your esophagus. The camera transmits real-time images to a monitor, allowing the doctor to see the inside lining of your esophagus in detail and identify any suspicious areas.^[6]^[8]

During the endoscopy, if your doctor sees anything that looks abnormal, they can immediately perform a biopsy. A biopsy involves removing a very small sample of tissue from the suspicious area. Special cutting tools are passed through the endoscope, and tiny pieces of tissue are carefully removed from the inside of your esophagus. These tissue samples are then sent to a laboratory, where a specialist called a pathologist examines them under a microscope to look for cancer cells. The biopsy is the only way to confirm whether cancer is present and, if so, what type it is.^[8]

Staging Tests After Diagnosis

Once a diagnosis of esophageal squamous cell carcinoma is confirmed through biopsy, additional tests are needed to determine how far the cancer has spread. This process is called staging, and it is crucial for planning the most appropriate treatment. Staging helps doctors understand whether the cancer is confined to the esophagus or has spread to nearby lymph nodes or distant organs such as the liver, lungs, or bones.^[8]

A computed tomography scan, commonly known as a CT scan, is frequently used for staging. This test creates detailed, three-dimensional images of your body by taking multiple X-ray pictures from different angles and combining them with computer processing. A CT scan of your neck, chest, and abdomen can identify the primary tumor and show whether cancer has spread to lymph nodes or other organs. Sometimes doctors combine CT scanning with positron emission tomography, creating a CT-PET scan, which provides even more detailed information about tumor location and spread.^[5]

Another valuable staging tool is endoscopic ultrasound, or EUS. This technique combines an ultrasound probe mounted on an endoscope, allowing doctors to obtain detailed images of the layers of the esophageal wall and nearby structures. Endoscopic ultrasound is particularly helpful for staging early cancers and determining how deeply a tumor has grown into the esophageal wall and whether nearby lymph nodes are involved.^[5]

For tumors located in the upper or middle part of the esophagus, where there is a possibility that the cancer might have invaded the airway—including the trachea or bronchi—your doctor may also recommend a bronchoscopy. This is a procedure similar to endoscopy but focuses on examining the airways to check for tumor involvement.^[5]

Understanding the Grade of Your Cancer

When the pathologist examines your biopsy tissue under a microscope, they don’t just look for cancer cells—they also assess how abnormal those cells appear compared to normal, healthy cells. This assessment is called grading. The grade gives your doctor important information about how the cancer might behave and helps guide treatment decisions.^[3]

Cancer cells are graded on a scale from 1 to 3. Grade 1 cells, also called low-grade or well-differentiated cells, look most similar to normal cells and tend to grow more slowly. Grade 2 cells, or moderately differentiated cells, look somewhat like normal cells. Grade 3 cells, also called high-grade or poorly differentiated cells, look very abnormal and nothing like normal cells. These high-grade cancers tend to grow and spread more quickly than low-grade cancers.^[3]

The concept of differentiation refers to how mature and specialized cells are. As normal cells grow and mature, they become specialized for their specific role and location in the body. Cancer cells that still resemble normal cells are considered well differentiated, while those that look very immature and undeveloped are poorly differentiated.^[3]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for esophageal squamous cell carcinoma, you will need to undergo specific diagnostic tests that serve as standard criteria for enrollment. Clinical trials have strict eligibility requirements to ensure that participants are appropriate for the experimental treatment being studied and that results can be accurately measured and compared.^[4]

The staging process described earlier—using endoscopy with biopsy, CT scans, CT-PET scans, and endoscopic ultrasound—forms the foundation of clinical trial qualification testing. Accurate staging is essential because most clinical trials enroll only patients whose cancer is at a specific stage. For example, some trials focus exclusively on early-stage disease, while others are designed for locally advanced or metastatic cancer.^[5]

Tissue samples from your biopsy may also be used for additional laboratory tests that are becoming increasingly important for clinical trial enrollment. These include tests for specific biomarkers or genetic characteristics of the tumor. For instance, some clinical trials now require testing for programmed death-ligand 1, commonly abbreviated as PD-L1, which is a protein found on some cancer cells. The level of PD-L1 expression can help predict whether a patient might benefit from certain immunotherapy treatments. Two common measurements used are the tumor proportion score (TPS) and the combined positive score (CPS).^[7]

Some clinical trials also require patients to have adequate organ function before enrollment. This means you may need blood tests to check your kidney and liver function, as well as blood cell counts. These tests, collectively known as clinical chemistry tests, analyze components in your blood serum or plasma to ensure your body can safely tolerate the experimental treatment being studied.^[9]

⚠️ Important

Clinical trials represent an important opportunity for patients with esophageal squamous cell carcinoma to access cutting-edge treatments that are not yet widely available. Recent advances in immunotherapy, in particular, have significantly changed treatment approaches for this disease, and many of these breakthroughs first became available through clinical trials. If you are interested in clinical trials, discuss this option with your healthcare team, who can help determine whether you might be eligible for any ongoing studies.

Performance status assessment is another common requirement for clinical trial enrollment. Your doctor will evaluate your ability to carry out daily activities and self-care tasks. This assessment helps researchers understand whether you are well enough to participate in the trial and tolerate the treatment being studied. Various standardized scales are used to measure performance status, and trial protocols specify minimum performance levels required for participation.^[4]

For trials studying new surgical techniques or combined treatment approaches involving surgery, additional imaging tests may be required. These might include more detailed CT or MRI scans to precisely measure tumor size and location, or specialized tests to evaluate whether the tumor is potentially removable with surgery. The term resectable means that a tumor appears to be removable through surgery, while unresectable means the tumor has grown in such a way that complete surgical removal is not possible.^[4]

It’s worth noting that diagnostic testing for clinical trials often involves more frequent monitoring than standard care. If you enroll in a trial, you can expect to undergo regular imaging scans, blood tests, and other assessments at specified intervals throughout your participation. This intensive monitoring serves two purposes: it helps ensure your safety during the experimental treatment, and it provides researchers with the detailed data needed to evaluate whether the new treatment is working.^[7]

Prognosis and Survival Rate

Prognosis

The outlook for patients with oesophageal squamous cell carcinoma depends on several important factors. The stage at which the cancer is diagnosed is the single most important factor affecting prognosis. When cancer is detected at stage 1, while still confined to the inner layers of the esophagus, the chances of successful treatment are significantly better than when it has spread to lymph nodes or distant organs. Unfortunately, because this cancer often doesn’t cause noticeable symptoms until it has grown substantially, the majority of patients are diagnosed at advanced stages.^[1]

The grade of the cancer cells also influences prognosis. Low-grade tumors, where cancer cells still resemble normal cells, tend to grow more slowly and respond better to treatment than high-grade tumors with very abnormal-appearing cells. The location of the tumor within the esophagus matters as well—tumors in the upper esophagus can be more challenging to treat with surgery, while those in the middle or lower portions may have different treatment options available.^[2]^[3]

Your overall health and fitness level also play a crucial role in determining prognosis. Patients who are generally healthy and able to carry out normal daily activities typically tolerate treatment better and may have better outcomes than those with significant other medical conditions. Age is another consideration, though it is less important than overall health status. The presence of weight loss and nutritional problems at diagnosis can negatively affect prognosis, as these issues can make it harder to complete intensive treatments.^[4]

Recent advances in treatment, particularly the development of immunotherapy drugs, have begun to improve outcomes for some patients with esophageal squamous cell carcinoma. Patients whose tumors express certain biomarkers, such as PD-L1, may have additional treatment options available that can extend survival and improve quality of life. Medical researchers continue to work on new treatments that may further improve prognosis in the future.^[7]

Survival rate

The five-year survival rate for esophageal squamous cell carcinoma is generally poor, though it varies significantly depending on the stage at diagnosis. Statistics from England show that almost 65 out of 100 people (almost 65%) with stage 1 oesophageal cancer survive for five years or more after diagnosis. This drops to around 30 out of 100 people (around 30%) for stage 2 cancer, and around 20 out of 100 people (around 20%) for stage 3 cancer. For stage 4 cancer, only about 5 out of 100 people (5%) survive for four years or more.^[17]

Looking at all stages combined, statistics from England and Wales show that around 45 out of every 100 people (around 45%) with oesophageal cancer survive for one year or more after diagnosis. More than 15 out of every 100 (more than 15%) survive for five years or more, and almost 15 out of every 100 (almost 15%) survive for ten years or more. These figures represent net survival, which estimates how many people survive their cancer after accounting for the fact that some people would have died from other causes even if they hadn’t had cancer.^[17]

It’s crucial to remember that these statistics are based on large groups of people diagnosed several years ago and followed over time. They cannot predict what will happen in your individual case. Many factors can influence your personal outcome, including your specific cancer characteristics, your overall health, the treatments you receive, and how well you respond to those treatments. Additionally, treatments for esophageal cancer continue to improve, so people diagnosed today may have better outcomes than these historical statistics suggest.^[17]

The five-year survival rate for esophageal squamous cell carcinoma as a global statistic remains concerning, which underscores the pressing need for earlier detection methods and more effective treatments. This is why researchers worldwide are actively investigating new approaches to both diagnosis and treatment of this challenging disease.^[4]

#1 Clinical Trials Search in Europe